Get the latest Science News and Discoveries

Are New Alzheimer’s Drugs All They Promise To Be?

Researchers question the impact of amyloid immunotherapy on Alzheimer's, highlighting the small benefits versus significant risks and costs. Despite regulatory approval by the FDA, other bodies like the EMA express reservations, reflecting broader concerns about these treatments' real-world effic

None

Get the Android app